AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
MEDICAL
Schering-Plough in criminal probe
The maker of allergy-fighter Claritin and other drugs signaled it may soon face federal indictments. The U.S. Attorney's Mass. office is probing Schering-Plough for allegedly selling unapproved drugs, giving false price info to the government and obstructing justice by destroying documents related to a government probe. Schering fell 2%.
Viagra rival set to launch this year
Bayer and GlaxoSmithKline's Levitra was found to have no major side-effects by an FDA panel, suggesting the impotence drug could get a final OK by the 2nd half. It's already OK for Europe and some parts of Latin America. Global sales could top $1 bil. Bayer rose 1%, GSK slid 2%.
ImClone up 21% on Erbitux hopes
Investors expect positive data on its Erbitux cancer drug from its partner, Germany's Merck, over the weekend at an American Society of Clinical Oncology meeting. ImClone ...